Ironwood Pharmaceuticals (IRWD) AGM 2024 summary

Opening remarks and agenda

• Meeting called to order by the Chair, conducted virtually via live audio webcast.

• Board members, executive officers, and external auditor introduced; notice of meeting confirmed.

• Quorum presumed present; voting procedures and shareholder list access explained.

Shareholder proposals

• Three proposals presented: election of nine directors, advisory vote on executive compensation, and ratification of the independent auditor.

• No additional nominations or proposals were received in advance.

Overview of voting outcomes

• All nine director nominees elected by plurality of votes cast.

• Advisory vote on executive compensation approved by majority.

• Ratification of Ernst & Young LLP as independent auditor for 2024 approved by majority.

• Final voting results to be filed with the SEC via Form 8-K.